JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 62.0%

Neg 0% Neu 62% Pos 0%

JP Morgan analyst Jessica Fye reinstates Immunocore Holdings (NASDAQ:IMCR) with a Overweight and announces $50 price target.